[go: up one dir, main page]

MX2022011310A - Azabiciclo y derivados de diazepina para tratar trastornos oculares. - Google Patents

Azabiciclo y derivados de diazepina para tratar trastornos oculares.

Info

Publication number
MX2022011310A
MX2022011310A MX2022011310A MX2022011310A MX2022011310A MX 2022011310 A MX2022011310 A MX 2022011310A MX 2022011310 A MX2022011310 A MX 2022011310A MX 2022011310 A MX2022011310 A MX 2022011310A MX 2022011310 A MX2022011310 A MX 2022011310A
Authority
MX
Mexico
Prior art keywords
azabicyclo
treating ocular
diazepine derivatives
ocular disorders
present
Prior art date
Application number
MX2022011310A
Other languages
English (en)
Inventor
David Ellis
Howard Allen Ketelson
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MX2022011310A publication Critical patent/MX2022011310A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente divulgación provee en un aspecto, derivados de azabiciclo y diazepina útiles como moduladores de receptores muscarínicos. En otro aspecto, la presente invención proporciona composiciones farmacéuticas para tratar enfermedades oculares, las composiciones comprenden al menos un modulador del receptor muscarínico.
MX2022011310A 2017-11-03 2020-07-13 Azabiciclo y derivados de diazepina para tratar trastornos oculares. MX2022011310A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762581073P 2017-11-03 2017-11-03
US201862749610P 2018-10-23 2018-10-23

Publications (1)

Publication Number Publication Date
MX2022011310A true MX2022011310A (es) 2022-10-07

Family

ID=64267873

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020004580A MX2020004580A (es) 2017-11-03 2018-11-02 Azabiciclo y derivados de diazepina para tratar trastornos oculares.
MX2022011310A MX2022011310A (es) 2017-11-03 2020-07-13 Azabiciclo y derivados de diazepina para tratar trastornos oculares.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020004580A MX2020004580A (es) 2017-11-03 2018-11-02 Azabiciclo y derivados de diazepina para tratar trastornos oculares.

Country Status (12)

Country Link
US (3) US11306090B2 (es)
EP (1) EP3704117B1 (es)
JP (3) JP7065180B2 (es)
KR (1) KR20200083976A (es)
CN (1) CN111247147A (es)
AU (3) AU2018362010B2 (es)
BR (1) BR112020007744A2 (es)
CA (2) CA3205816A1 (es)
MX (2) MX2020004580A (es)
SG (1) SG11202002692XA (es)
TW (2) TWI826399B (es)
WO (2) WO2019087149A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11117869B2 (en) * 2019-02-01 2021-09-14 Aerie Pharmaceuticals, Inc. Compounds, compositions and methods for treatment of myopia
CN119110721A (zh) 2022-09-11 2024-12-10 爱尔康公司 包含苄基阿托品的水性药物组合物及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1165037B (de) * 1961-11-21 1964-03-12 Dr. Schwarz Arzneimittelfabrik G.m.b.H., Monheim (RhId.) Verfahren zur Herstellung von Estern quaternärer Atropiniumsalze.
GB994493A (en) * 1963-02-06 1965-06-10 Lepetit Spa Tropine derivative
DE1670177A1 (de) 1966-12-28 1970-11-12 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen N-substituierten Noratropiniumsalzen
US5223528A (en) * 1986-03-17 1993-06-29 University Of Florida Anticholinergic compounds, composititons and methods of treatment
NZ529615A (en) 2001-05-25 2005-07-29 Valley Forge Pharmaceuticals Pirenzepine ophthalmic gel
FR2834511B1 (fr) 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
CN1546490A (zh) * 2003-12-15 2004-11-17 常俊标 不对称双羟基托品类生物碱及其合成新方法和药物用途
CN1283639C (zh) 2004-06-08 2006-11-08 吴建梅 治疗近视眼的哌仑西平有机酸盐及其滴眼剂
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
SI2657234T1 (sl) 2010-12-22 2017-06-30 Meiji Seika Pharma Co., Ltd. Derivat optično-aktivnega diazabiciklooktana in metoda za njegovo izdelavo

Also Published As

Publication number Publication date
KR20200083976A (ko) 2020-07-09
AU2023202036B2 (en) 2024-08-08
JP7777613B2 (ja) 2025-11-28
EP3704117B1 (en) 2026-01-28
AU2018362010A1 (en) 2020-04-09
AU2021205100A1 (en) 2021-08-12
RU2020117733A (ru) 2021-12-03
WO2019087146A1 (en) 2019-05-09
US11306090B2 (en) 2022-04-19
BR112020007744A2 (pt) 2020-10-13
US20240132497A1 (en) 2024-04-25
EP3704117A1 (en) 2020-09-09
JP2022101654A (ja) 2022-07-06
AU2023202036A1 (en) 2023-05-04
US20210179616A1 (en) 2021-06-17
WO2019087149A1 (en) 2019-05-09
JP7065180B2 (ja) 2022-05-11
SG11202002692XA (en) 2020-05-28
CN111247147A (zh) 2020-06-05
JP2024041971A (ja) 2024-03-27
CA3205816A1 (en) 2019-05-09
US12247028B2 (en) 2025-03-11
TWI826399B (zh) 2023-12-21
CA3076457A1 (en) 2019-05-09
CA3076457C (en) 2023-09-19
TW201922731A (zh) 2019-06-16
JP2020536922A (ja) 2020-12-17
MX2020004580A (es) 2020-12-03
US11884666B2 (en) 2024-01-30
TWI852865B (zh) 2024-08-11
TW202417440A (zh) 2024-05-01
AU2021205100B2 (en) 2023-01-05
AU2018362010B2 (en) 2021-05-13
US20220267328A1 (en) 2022-08-25

Similar Documents

Publication Publication Date Title
NZ737399A (en) Ccr2 modulators
PH12015502621A1 (en) Estrogen receptor modulator and uses thereof
PH12019502058A1 (en) Farnesoid x receptor agonists and uses thereof
MX2018009752A (es) 1,2,3,-triazoles sustituidos como moduladores de nmda selectivos de nr2b.
EA201791239A8 (ru) ТЕТРАГИДРОПИРИДО[3,4-b]ИНДОЛОВЫЕ МОДУЛЯТОРЫ ЭСТРОГЕНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ
MX2015011132A (es) Moduladores policiclicos del receptor de estrogenos y sus usos.
MX2015016171A (es) Moduladores del receptor de estrogeno de azetidina y usos de los mismos.
PH12014502095A1 (en) Estrogen receptor modulators and uses thereof
MX2021015500A (es) Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b.
MX363118B (es) Derivados de pirazol aminopirimidina como moduladores de cinasa 2 de repeticion rica en leucina (lrrk2).
PH12014501351A1 (en) Fluorinated estrogen receptor modulators and uses thereof
PH12018501731A1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m1
PH12013500481A1 (en) Estrogen receptor modulators and uses thereof
PH12012502419A1 (en) Estrogen receptor modulators and uses thereof
MX2015009773A (es) Moduladores de receptores nmda de espiro-lactama y sus usos.
MX2018000352A (es) 4-azaindoles sustituidos y su uso como moduladores del receptor glun2b.
MX2020007731A (es) Compuestos moduladores de receptor de estrogeno.
CR20210615A (es) Pirazolo piridinas heteroaromáticas sustituidas y su uso como moduladores del receptor glun2b
NZ736055A (en) Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
CR20210580A (es) Amidas depirazol-piridina sustituidos y su uso como moduladores del receptor glun2b
WO2014066799A3 (en) Modulators of resistant androgen receptor
MX2014010537A (es) Moduladores de receptor x del higado (lxr) para el tratamiento de enfermedades, trastornos y condiciones dermicas.
BR112021014566A2 (pt) Moduladores de gpr35
EP4219507A3 (en) Thienopyrimidinone nmda receptor modulators and uses thereof
MX2022011310A (es) Azabiciclo y derivados de diazepina para tratar trastornos oculares.